Fluzone Trivalent Northern Hemisphere Injection, Suspension
Product Images NDC 83703-087

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone Trivalent Northern Hemisphere (NDC 83703-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bamboo Us Bidco Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FLUZONE Influenza Vaccine 2026-2027 Formula packaging label by Sanofi. This intramuscular injection contains 10 single-dose prefilled syringes of 0.5 mL each, for use in individuals 6 months and older. Storage instructions specify not to freeze, with recommended temperature 2 to 8°C (35 to 46°F). The label includes details on vaccine composition and manufacturing.*

FDA Label Image

33 (Image 2)

Label of Influenza Vaccine Fluzone, 2026-2027 Formula, single-dose 0.5 mL injection for intramuscular use. The label notes it contains no preservative and is manufactured by Sanofi Vaccines US Inc. The label includes prescribing information and fields for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.